Literature DB >> 20558816

Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages.

Mingzhen Li1, Demin Yu, Kevin Jon Williams, Ming-Lin Liu.   

Abstract

OBJECTIVE: To investigate whether exposure of human monocytes/macrophages to tobacco smoke induces their release of membrane microvesicles (MVs) that carry tissue factor (TF) released from cells, whether smoke-induced MVs are procoagulant, and what cellular processes might be responsible for their production. METHODS AND
RESULTS: We found that exposure of human THP-1 monocytes and primary human monocyte-derived macrophages to 3.75% tobacco smoke extract (TSE) significantly increased their total and TF-positive MV generation. More importantly, MVs released from TSE-treated human monocytes/macrophages exhibited 3 to 4 times the procoagulant activity of control MVs, as assessed by TF-dependent generation of factor Xa. Exposure to TSE increased TF mRNA and protein expression and cell surface TF display by both THP-1 monocytes and primary human monocyte-derived macrophages. In addition, TSE exposure caused activation of C-Jun-N-terminal kinase (JNK), p38, extracellular signal regulated kinase (ERK) mitogen-activated protein kinases (MAPK), and apoptosis (a major mechanism for MV generation). Treatment of THP-1 cells with inhibitors of ERK, MAP kinase kinase (MEK), Ras, or caspase 3, but not p38 or JNK, significantly blunted TSE-induced apoptosis and MV generation. Surprisingly, neither ERK nor caspase 3 inhibition altered the induction of cell surface TF display by TSE, indicating an effect solely on MV release. Inhibition of ERK or caspase 3 essentially abolished TSE-induced generation of procoagulant MVs from THP-1 monocytes.
CONCLUSIONS: Tobacco smoke exposure of human monocytes/macrophages induces cell surface TF display, apoptosis, and ERK- and caspase 3-dependent generation of biologically active procoagulant MVs. These processes may be novel contributors to the pathological hypercoagulability of active and secondhand smokers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558816      PMCID: PMC2939448          DOI: 10.1161/ATVBAHA.110.209577

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  57 in total

1.  Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity.

Authors:  S Matetzky; S Tani; S Kangavari; P Dimayuga; J Yano; H Xu; K Y Chyu; M C Fishbein; P K Shah; B Cercek
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

2.  Recruitment of labelled monocytes by experimental venous thrombi.

Authors:  C L McGuinness; J Humphries; M Waltham; K G Burnand; M Collins; A Smith
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

3.  Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats.

Authors:  F D'Agostini; R M Balansky; A Izzotti; R A Lubet; G J Kelloff; S De Flora
Journal:  Carcinogenesis       Date:  2001-03       Impact factor: 4.944

4.  Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives.

Authors:  H Hölschermann; H M Terhalle; U Zakel; U Maus; B Parviz; H Tillmanns; W Haberbosch
Journal:  Thromb Haemost       Date:  1999-12       Impact factor: 5.249

5.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.

Authors:  M Guha; M A O'Connell; R Pawlinski; A Hollis; P McGovern; S F Yan; D Stern; N Mackman
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

6.  Acute cigarette smoke exposure induces apoptosis of alveolar macrophages.

Authors:  K Aoshiba; J Tamaoki; A Nagai
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-12       Impact factor: 5.464

7.  Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.

Authors:  Florian Bea; Mirja H Puolakkainen; Timothy McMillen; Francesca N Hudson; Nigel Mackman; Cho Chou Kuo; Lee Ann Campbell; Michael E Rosenfeld
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

8.  Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.

Authors:  Antonia Sambola; Julio Osende; James Hathcock; Michael Degen; Yale Nemerson; Valentin Fuster; Jill Crandall; Juan Jose Badimon
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

Review 9.  Why is environmental tobacco smoke more strongly associated with coronary heart disease than expected? A review of potential biases and experimental data.

Authors:  G Howard; M J Thun
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

10.  Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells.

Authors:  Gary R Hellermann; Szilvia B Nagy; Xiaoyuan Kong; Richard F Lockey; Shyam S Mohapatra
Journal:  Respir Res       Date:  2002-07-10
View more
  55 in total

Review 1.  Pathogenic roles of microvesicles in diabetic retinopathy.

Authors:  Wei Zhang; Song Chen; Ming-Lin Liu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

2.  Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.

Authors:  Yan Chen; Guangping Li; Yanxia Liu; Victoria P Werth; Kevin Jon Williams; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2016-03-09       Impact factor: 6.384

Review 3.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 4.  The biology behind the atherothrombotic effects of cigarette smoke.

Authors:  Adam Csordas; David Bernhard
Journal:  Nat Rev Cardiol       Date:  2013-02-05       Impact factor: 32.419

5.  Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.

Authors:  Damien Gheldof; Hélène Haguet; Jean-Michel Dogné; Céline Bouvy; Carlos Graux; Fabienne George; Anne Sonet; Christian Chatelain; Bernard Chatelain; François Mullier
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

6.  Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.

Authors:  Ming-Lin Liu; Rosario Scalia; Jawahar L Mehta; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-19       Impact factor: 8.311

Review 7.  Microparticles: new light shed on the understanding of venous thromboembolism.

Authors:  Lin Zhou; Xiao-long Qi; Ming-xin Xu; Yu Mao; Ming-lin Liu; Hao-ming Song
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

8.  Macrophages treated with particulate matter PM2.5 induce selective neurotoxicity through glutaminase-mediated glutamate generation.

Authors:  Fang Liu; Yunlong Huang; Fang Zhang; Qiang Chen; Beiqing Wu; Wei Rui; Jialin C Zheng; Wenjun Ding
Journal:  J Neurochem       Date:  2015-05-19       Impact factor: 5.372

9.  Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke.

Authors:  Chun-Jun Li; Yu Liu; Yan Chen; Demin Yu; Kevin Jon Williams; Ming-Lin Liu
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

Review 10.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.